The emerging role of KIAA1199 in cancer development and therapy - 16/04/21
páginas | 6 |
Iconografías | 2 |
Vídeos | 0 |
Otros | 0 |
Abstract |
KIAA1199, also known as CEMIP or HYBID, is an important member of the Human Unidentified Gene-Encoded (HUGE) database. Accumulated evidence has revealed that KIAA1199 is associated with tumor progression and metastasis in numerous malignancies, including colorectal, liver, gastric, pancreatic, breast, lung, prostate, ovarian and papillary thyroid cancers. As an oncogene, it plays crucial role in the proliferation, apoptosis, invasion and migration of various tumor cells. In addition, KIAA1199 is also involved in the regulation of multiple signal pathways such as epithelial-mesenchymal transition (EMT), Wnt/ β-catenin, MEK/ERK and PI3K/Akt. In this review, we summarized up to date advancement on the role of KIAA1199 in human cancer development, progression, and metastasis. We also addressed KIAA1199 as a potential therapeutic target for cancer therapy.
El texto completo de este artículo está disponible en PDF.Highlights |
• | KIAA1199 is highly expressed in various human cancers. |
• | KIAA1199 regulates cell proliferation, apoptosis, invasion and migration. |
• | KIAA1199, as an oncogene, is a hub linking various signaling pathways. |
• | KIAA1199 may be a novel targeted gene for cancer therapy. |
Keywords : KIAA1199, Cancer, Therapy, EMT, Wnt/ β-catenin
Esquema
Vol 138
Artículo 111507- juin 2021 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.
¿Ya suscrito a @@106933@@ revista ?